biostudies-literatureKotseva KNovo NordiskAmgenESCPfizerPreventive Cardiology TrustAstraZenecaSanofiAmgen, Daiichi Sankyo, Eli LillyNovartise002704https://www.ebi.ac.uk/biostudies/studies/S-EPMC11481111biostudies-literatureUnknown11(2)<h4>Background</h4>Implementation of the cardiovascular disease (CVD) prevention guidelines in the UK has been repeatedly evaluated under the auspices of the British Cardiovascular Society in three Action on Secondary and Primary Prevention by Intervention to Reduce Events (ASPIRE) surveys in 1994-1995, 2008-2010 and 2017-2019. The primary care arm of ASPIRE-2-PREVENT (A-3-P) was conducted to evaluate lifestyle and medical risk factor management in people at high risk of atherosclerotic CVD in everyday clinical practice.<h4>Methods</h4>A-3-P was a cross-sectional survey in 27 general practices and health centres across 5 English National Health Service regions. Patients with no history of atherosclerotic CVD started on blood pressure and/or lipid and/or glucose lowering treatments were ideOpen heartChallenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.PMC11481111N/AASPIRE-3-PREVENT InvestigatorsOliver AMartin ZTalbot CWilson HTaylor SWilson JColes RTimmins JTaylor JBallintine AMononga SOwen LRosenberg LArthur MCartwright SShillito SRichardson SGhuman NNobeebaccus HThornley CBeck KFox RZerominska MKhan O Hussein UCook JDavies JRyan JBeecham JIsaew ASteed SSteel LRooney JOakley MThomas CHolt TAndrew LJones CQamar NKelly DJones DLHollishead SMason TCrowe RCorbett DHobbs RDunne ANaylo CCox CHorsley RClarke JWood DNyguyen TMaslen SWytrykowski SBrown AAdamska ASpannuth SChauhan NDean SMckee SSymonds RBrown CBassett PSpannuth FJennings CAgasou AWinch CHowell JHunt SHibbell RTaylor LSGibbon CAdamska SWooding NDuff KJones SGarnham SCoote NHollier KGriffiths PDiprose DHembrough TTomlinson EOgburn EStone MChaytor LLonsdale DMazilu-Wood SKotseva KSimm JDoyle FShukla DGlover VUddin SBell CGalbraith-Gibbons SAtkin PPriddis KSteadman PSevenoaks TBosel-Doyle SfalseChallenge of cardiovascular prevention in primary care: achievement of lifestyle, blood pressure, lipids and diabetes targets for primary prevention in England - results from ASPIRE-3-PREVENT cross-sectional survey.<h4>Background</h4>Implementation of the cardiovascular disease (CVD) prevention guidelines in the UK has been repeatedly evaluated under the auspices of the British Cardiovascular Society in three Action on Secondary and Primary Prevention by Intervention to Reduce Events (ASPIRE) surveys in 1994-1995, 2008-2010 and 2017-2019. The primary care arm of ASPIRE-2-PREVENT (A-3-P) was conducted to evaluate lifestyle and medical risk factor management in people at high risk of atherosclerotic CVD in everyday clinical practice.<h4>Methods</h4>A-3-P was a cross-sectional survey in 27 general practices and health centres across 5 English National Health Service regions. Patients with no history of atherosclerotic CVD started on blood pressure and/or lipid and/or glucose lowering treatments were ide2024-01-01T00:00:00Z2024 Oct2025-04-04T00:33:50.715Z2025-04-04T00:33:50.715ZS-EPMC114811113941430910.1136/openhrt-2024-002704